These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34621165)

  • 1. Lack of Major Involvement of Common
    Macías Y; García-Menaya JM; Martí M; Cordobés C; Jurado-Escobar R; Cornejo-García JA; Torres MJ; Blanca-López N; Canto G; Blanca M; Laguna JJ; Bartra J; Rosado A; Fernández J; García-Martín E; Agúndez JAG
    Front Pharmacol; 2021; 12():648262. PubMed ID: 34621165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?
    Agúndez JA; García-Martín E; Martínez C
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):607-20. PubMed ID: 19422321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical pharmacogenomics for CYP2C8 and CYP2C9: general concepts and application to the use of NSAIDs].
    Martínez C; Blanco G; García-Martín E; Agúndez JA
    Farm Hosp; 2006; 30(4):240-8. PubMed ID: 17022718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FCERI and Histamine Metabolism Gene Variability in Selective Responders to NSAIDS.
    Amo G; Cornejo-García JA; García-Menaya JM; Cordobes C; Torres MJ; Esguevillas G; Mayorga C; Martinez C; Blanca-Lopez N; Canto G; Ramos A; Blanca M; Agúndez JA; García-Martín E
    Front Pharmacol; 2016; 7():353. PubMed ID: 27746735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics and Pain Treatment with a Focus on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Antidepressants: A Systematic Review.
    Zobdeh F; Eremenko II; Akan MA; Tarasov VV; Chubarev VN; Schiöth HB; Mwinyi J
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
    Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
    Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
    Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding.
    Blanco G; Martínez C; Ladero JM; Garcia-Martin E; Taxonera C; Gamito FG; Diaz-Rubio M; Agundez JA
    Pharmacogenet Genomics; 2008 Jan; 18(1):37-43. PubMed ID: 18216720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype.
    van Dijk KN; Plat AW; van Dijk AA; Piersma-Wichers M; de Vries-Bots AM; Slomp J; de Jong-van den Berg LT; Brouwers JR
    Thromb Haemost; 2004 Jan; 91(1):95-101. PubMed ID: 14691574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain Management.
    Jaja C; Bowman L; Wells L; Patel N; Xu H; Lyon M; Kutlar A
    Clin Transl Sci; 2015 Aug; 8(4):272-80. PubMed ID: 25640739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression and function of CYP2C isoforms in human intestine and liver.
    Läpple F; von Richter O; Fromm MF; Richter T; Thon KP; Wisser H; Griese EU; Eichelbaum M; Kivistö KT
    Pharmacogenetics; 2003 Sep; 13(9):565-75. PubMed ID: 12972955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
    Jaturapatporn D; Isaac MG; McCleery J; Tabet N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of possible anaphylaxis to ASA and structurally unrelated NSAIDs.
    Edgerley S; Kim H
    Allergy Asthma Clin Immunol; 2023 Sep; 19(1):81. PubMed ID: 37684617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study.
    Arfè A; Scotti L; Varas-Lorenzo C; Nicotra F; Zambon A; Kollhorst B; Schink T; Garbe E; Herings R; Straatman H; Schade R; Villa M; Lucchi S; Valkhoff V; Romio S; Thiessard F; Schuemie M; Pariente A; Sturkenboom M; Corrao G;
    BMJ; 2016 Sep; 354():i4857. PubMed ID: 27682515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Polymorphisms and in Vitro Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants.
    Hiratsuka M
    Biol Pharm Bull; 2016; 39(11):1748-1759. PubMed ID: 27803446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the results of analgesic therapy. Results of the Russian multicentre study of NOTE (NSAID: Open-label Trial of Efficacy).
    Karateev AE; Pogozheva EY; Filatova EA; Amirjanova VN; Lila AM; Antipova OV; Babaeva AR; Volkorezova AV; Davydova AF; Davtyan VG; Zonova EV; Ivanova ON; Kalinina NN; Kiseleva NI; Knyazeva LA; Kulikov AI; Nesmeyanova OB; Mazurov VI; Masneva LV; Menshikova LV; Obuhova IV; Otteva EN; Salnikova TS; Shсhendrygin IN; Yakupova SP
    Ter Arkh; 2018 Jun; 90(6):65-73. PubMed ID: 30701907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
    Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
    Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Variants in Cytosolic Phospholipase A2 Associated With Nonsteroidal Anti-Inflammatory Drug-Induced Acute Urticaria/Angioedema.
    Jurado-Escobar R; Doña I; Triano-Cornejo J; Perkins JR; Pérez-Sánchez N; Testera-Montes A; Labella M; Bartra J; Laguna JJ; Estravís M; Agúndez JAG; Torres MJ; Cornejo-García JA
    Front Pharmacol; 2021; 12():667824. PubMed ID: 33995098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
    García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
    Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.